Back to Search Start Over

EMT activates exocytotic Rabs to coordinate invasion and immunosuppression in lung cancer.

Authors :
Xiao GY
Tan X
Rodriguez BL
Gibbons DL
Wang S
Wu C
Liu X
Yu J
Vasquez ME
Tran HT
Xu J
Russell WK
Haymaker C
Lee Y
Zhang J
Solis L
Wistuba II
Kurie JM
Source :
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2023 Jul 11; Vol. 120 (28), pp. e2220276120. Date of Electronic Publication: 2023 Jul 05.
Publication Year :
2023

Abstract

Epithelial-to-mesenchymal transition (EMT) underlies immunosuppression, drug resistance, and metastasis in epithelial malignancies. However, the way in which EMT orchestrates disparate biological processes remains unclear. Here, we identify an EMT-activated vesicular trafficking network that coordinates promigratory focal adhesion dynamics with an immunosuppressive secretory program in lung adenocarcinoma (LUAD). The EMT-activating transcription factor ZEB1 drives exocytotic vesicular trafficking by relieving Rab6A, Rab8A, and guanine nucleotide exchange factors from miR-148a-dependent silencing, thereby facilitating MMP14-dependent focal adhesion turnover in LUAD cells and autotaxin-mediated CD8 <superscript>+</superscript> T cell exhaustion, indicating that cell-intrinsic and extrinsic processes are linked through a microRNA that coordinates vesicular trafficking networks. Blockade of ZEB1-dependent secretion reactivates antitumor immunity and negates resistance to PD-L1 immune checkpoint blockade, an important clinical problem in LUAD. Thus, EMT activates exocytotic Rabs to drive a secretory program that promotes invasion and immunosuppression in LUAD.

Details

Language :
English
ISSN :
1091-6490
Volume :
120
Issue :
28
Database :
MEDLINE
Journal :
Proceedings of the National Academy of Sciences of the United States of America
Publication Type :
Academic Journal
Accession number :
37406091
Full Text :
https://doi.org/10.1073/pnas.2220276120